Our findings demonstrate that Cdkn1a (p21) significantly contributes to the M1 pro‐inflammatory phenotype of microglia, offering potential therapeutic targets for mitigating neuroinflammation in stroke. This evidence concerns the gene CDKN1A and stroke disorder.